Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Children with a History of Multisystem Inflammatory Syndrome in Children: An International Survey.

Levi Hoste Antoni Soriano-Arandes Emilie Pauline Buddingh Elizabeth Whittaker Alexandre Belot Rolando Ulloa-Gutierrez Peter Olbrich Filomeen Haerynck

J Pediatr

Primary Immune Deficiency Research Laboratory, Department of Internal Diseases and Pediatrics, Centre for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Centre, Ghent University Hospital, Ghent, Belgium; Department of Internal Medicine and Pediatrics, Division of Pediatric Pulmonology, Infectious Diseases and Inborn Errors of Immunity, Ghent University Hospital, Ghent, Belgium. Electronic address:

Published: September 2022

The optimal severe acute respiratory syndrome coronavirus 2 vaccine strategy for patients with a history of multisystem inflammatory syndrome in children (MIS-C) is unclear. We performed an international survey (32 countries) and found substantial variations in vaccine policies. Respondents did not report relapses of MIS-C or other severe inflammatory side effects after severe acute respiratory syndrome coronavirus 2 vaccination in 273 patients with a history of MIS-C.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119291	PMC
http://dx.doi.org/10.1016/j.jpeds.2022.05.028	DOI Listing

Publication Analysis

Top Keywords

severe acute

acute respiratory

respiratory syndrome

syndrome coronavirus

coronavirus vaccination

history multisystem

multisystem inflammatory

inflammatory syndrome

syndrome children

patients history

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!